268 related articles for article (PubMed ID: 11205225)
1. A new cell proliferating marker: cytosolic thymidine kinase as compared to proliferating cell nuclear antigen in patients with colorectal carcinoma.
Wu J; Mao Y; He L; Wang N; Wu C; He Q; Skog S
Anticancer Res; 2000; 20(6C):4815-20. PubMed ID: 11205225
[TBL] [Abstract][Full Text] [Related]
2. Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and cDNA profiling.
Mao Y; Wu J; Skog S; Eriksson S; Zhao Y; Zhou J; He Q
Oncol Rep; 2005 May; 13(5):837-46. PubMed ID: 15809747
[TBL] [Abstract][Full Text] [Related]
3. A comparative study: immunohistochemical detection of cytosolic thymidine kinase and proliferating cell nuclear antigen in breast cancer.
Mao Y; Wu J; Wang N; He L; Wu C; He Q; Skog S
Cancer Invest; 2002; 20(7-8):922-31. PubMed ID: 12449723
[TBL] [Abstract][Full Text] [Related]
4. Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.
He Q; Mao Y; Wu J; Decker C; Merza M; Wang N; Eriksson S; Castro J; Skog S
Int J Oncol; 2004 Oct; 25(4):945-53. PubMed ID: 15375544
[TBL] [Abstract][Full Text] [Related]
5. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
Georgescu CV; Săftoiu A; Georgescu CC; Ciurea R; Ciurea T
J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558
[TBL] [Abstract][Full Text] [Related]
6. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival.
Nakamura T; Tabuchi Y; Nakae S; Ohno M; Saitoh Y
Cancer; 1996 Apr; 77(8 Suppl):1741-6. PubMed ID: 8608572
[TBL] [Abstract][Full Text] [Related]
7. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
[TBL] [Abstract][Full Text] [Related]
8. [The expressions of proliferating cell nuclear antigen (PCNA) in primary gallbladder carcinoma and its significance].
Qing D; Xia L; Zhang X
Zhonghua Wai Ke Za Zhi; 1995 Feb; 33(2):102-4. PubMed ID: 7656696
[TBL] [Abstract][Full Text] [Related]
9. Comparison of proliferating cell nuclear antigen versus the more standard measures of rectal mucosal proliferation rates in subjects with a history of colorectal cancer and normal age-matched controls.
Einspahr J; Alberts D; Xie T; Ritchie J; Earnest D; Hixson L; Powell M; Roe D; Grogan T
Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):359-66. PubMed ID: 7655331
[TBL] [Abstract][Full Text] [Related]
10. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
11. Cell proliferative activity in intraductal papillary-mucinous neoplasms and invasive ductal adenocarcinomas of the pancreas: an immunohistochemical study.
Terada T; Ohta T; Kitamura Y; Ashida K; Matsunaga Y
Arch Pathol Lab Med; 1998 Jan; 122(1):42-6. PubMed ID: 9448015
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
13. Expression of proliferating cell nuclear antigen(PCNA) in biopsy and autopsy specimens of gastric carcinoma.
He XB; Ii K; Muguruma N; Hayashi S; Ito S
J Med Invest; 1998 Feb; 44(3-4):149-53. PubMed ID: 9597802
[TBL] [Abstract][Full Text] [Related]
14. Relationship between immunohistochemical evaluation of thymidylate synthase and proliferating cell nuclear antigen labeling index in gastrointestinal carcinoma.
Kunimoto Y; Nakamura T; Ohno M; Kuroda Y
Oncol Rep; 2004 Dec; 12(6):1163-7. PubMed ID: 15547732
[TBL] [Abstract][Full Text] [Related]
15. Clinical validity of proliferating cell nuclear antigen as an objective marker for evaluating biologic features in patients with untreated prostate cancer.
Miyamoto S; Ito K; Kurokawa K; Suzuki K; Suzuki K; Yamanaka H
Int J Urol; 2006 Jun; 13(6):767-72. PubMed ID: 16834658
[TBL] [Abstract][Full Text] [Related]
16. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
[TBL] [Abstract][Full Text] [Related]
17. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence.
Risio M; Candelaresi G; Rossini FP
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):363-7. PubMed ID: 8102291
[TBL] [Abstract][Full Text] [Related]
18. Pan cycle expression of proliferating cell nuclear antigen in human colorectal cancer and its proliferative correlations.
Sawtell RM; Rew DA; Stradling RN; Wilson GD
Cytometry; 1995 Sep; 22(3):190-9. PubMed ID: 8556950
[TBL] [Abstract][Full Text] [Related]
19. Rectal mucosal proliferation, dietary factors, and the risk of colorectal adenomas.
Keku TO; Galanko JA; Murray SC; Woosley JT; Sandler RS
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):993-9. PubMed ID: 9829707
[TBL] [Abstract][Full Text] [Related]
20. Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of oesophageal squamous cell carcinomas.
Okuno Y; Nishimura Y; Kashu I; Ono K; Hiraoka M
Br J Cancer; 1999 May; 80(3-4):387-95. PubMed ID: 10408843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]